It’s simple: a clinical trial health system that enrols more patients will lead to faster treatment advances and, therefore, better outcomes for people with cancer.1 But, as it s
The Association of the British Pharmaceutical Industry (ABPI) has added five new patient organisation figures to its patient advisory council, set up to provide patient pe